Elijah M. Bolotin

721 total citations
17 papers, 569 citations indexed

About

Elijah M. Bolotin is a scholar working on Molecular Biology, Surgery and Biomaterials. According to data from OpenAlex, Elijah M. Bolotin has authored 17 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Surgery and 6 papers in Biomaterials. Recurrent topics in Elijah M. Bolotin's work include Nanoparticle-Based Drug Delivery (6 papers), RNA Interference and Gene Delivery (4 papers) and Pancreatic function and diabetes (4 papers). Elijah M. Bolotin is often cited by papers focused on Nanoparticle-Based Drug Delivery (6 papers), RNA Interference and Gene Delivery (4 papers) and Pancreatic function and diabetes (4 papers). Elijah M. Bolotin collaborates with scholars based in United States, Israel and Russia. Elijah M. Bolotin's co-authors include Yechezkel Barenholz, Noam Emanuel, M. Bansinath, Gilbert J. Grant, Herman Turndorf, Boris Piskoun, Rivka Cohen, Liliana K. Bar, Danilo D. Lasiç and Elyad Davidson and has published in prestigious journals such as Diabetes, Anesthesiology and Pharmaceutical Research.

In The Last Decade

Elijah M. Bolotin

17 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elijah M. Bolotin United States 9 243 231 168 89 83 17 569
Homer H. Chiang United States 14 187 0.8× 207 0.9× 144 0.9× 241 2.7× 67 0.8× 22 776
Jordan A. Stinson United States 13 93 0.4× 73 0.3× 62 0.4× 81 0.9× 56 0.7× 22 440
Sarbani Hazra India 14 99 0.4× 117 0.5× 56 0.3× 62 0.7× 73 0.9× 26 542
Lane V. Christensen United States 11 824 3.4× 202 0.9× 49 0.3× 96 1.1× 27 0.3× 11 1.0k
George R. Dakwar Belgium 16 250 1.0× 187 0.8× 129 0.8× 108 1.2× 62 0.7× 24 633
Kelli M. Luginbuhl United States 10 373 1.5× 243 1.1× 57 0.3× 94 1.1× 48 0.6× 12 686
Kevin Pham United States 13 142 0.6× 92 0.4× 191 1.1× 141 1.6× 3 0.0× 25 605
Jacqueline H. Cole United States 12 129 0.5× 47 0.2× 120 0.7× 205 2.3× 66 0.8× 29 699
James Floyd United States 11 204 0.8× 72 0.3× 149 0.9× 76 0.9× 27 0.3× 16 861
Jeff Henise United States 8 112 0.5× 151 0.7× 44 0.3× 180 2.0× 87 1.0× 13 496

Countries citing papers authored by Elijah M. Bolotin

Since Specialization
Citations

This map shows the geographic impact of Elijah M. Bolotin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elijah M. Bolotin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elijah M. Bolotin more than expected).

Fields of papers citing papers by Elijah M. Bolotin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elijah M. Bolotin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elijah M. Bolotin. The network helps show where Elijah M. Bolotin may publish in the future.

Co-authorship network of co-authors of Elijah M. Bolotin

This figure shows the co-authorship network connecting the top 25 collaborators of Elijah M. Bolotin. A scholar is included among the top collaborators of Elijah M. Bolotin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elijah M. Bolotin. Elijah M. Bolotin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Castillo, Gerardo M., et al.. (2024). Subcutaneous therapy for portal hypertension: PHIN-214, a partial vasopressin receptor 1A agonist. Biomedicine & Pharmacotherapy. 171. 116068–116068. 1 indexed citations
2.
Leporati, Anita, Suresh Gupta, Elijah M. Bolotin, et al.. (2019). Antiretroviral Hydrophobic Core Graft-Copolymer Nanoparticles: The Effectiveness against Mutant HIV-1 Strains and in Vivo Distribution after Topical Application. Pharmaceutical Research. 36(5). 73–73. 7 indexed citations
3.
Leporati, Anita, Михаил С. Новиков, Vladimir T. Valuev-Elliston, et al.. (2016). Hydrophobic-core PEGylated graft copolymer-stabilized nanoparticles composed of insoluble non-nucleoside reverse transcriptase inhibitors exhibit strong anti-HIV activity. Nanomedicine Nanotechnology Biology and Medicine. 12(8). 2405–2413. 7 indexed citations
4.
5.
Castillo, Gerardo M., Israel Rubinstein, Cynthia C. Jones, et al.. (2012). Protected Graft Copolymer Excipient Leads to a Higher Acute Maximum Tolerated Dose and Extends Residence Time of Vasoactive Intestinal Peptide Significantly Better than Sterically Stabilized Micelles. Pharmaceutical Research. 30(3). 670–682. 3 indexed citations
6.
Bogdanov, Alexei, Mary L. Mazzanti, Gerardo M. Castillo, & Elijah M. Bolotin. (2012). Protected Graft Copolymer (PGC) in Imaging and Therapy: A Platform for the Delivery of Covalently and Non-Covalently Bound Drugs. Theranostics. 2(6). 553–576. 21 indexed citations
7.
Medarova, Zdravka, Dale L. Greiner, Marytheresa A. Ifediba, et al.. (2011). Imaging the pancreatic vasculature in diabetes models. Diabetes/Metabolism Research and Reviews. 27(8). 767–772. 12 indexed citations
8.
9.
Castillo, Gerardo M., et al.. (2011). Extending Residence Time and Stability of Peptides by Protected Graft Copolymer (PGC) Excipient: GLP-1 Example. Pharmaceutical Research. 29(1). 306–318. 11 indexed citations
10.
Medarova, Zdravka, et al.. (2007). Noninvasive Magnetic Resonance Imaging of Microvascular Changes in Type 1 Diabetes. Diabetes. 56(11). 2677–2682. 38 indexed citations
11.
Grant, Gilbert J., Yechezkel Barenholz, Elijah M. Bolotin, et al.. (2004). A Novel Liposomal Bupivacaine Formulation to Produce Ultralong-Acting Analgesia. Anesthesiology. 101(1). 133–137. 127 indexed citations
12.
Grant, Gilbert J., Yechezkel Barenholz, Boris Piskoun, et al.. (2001). DRV Liposomal Bupivacaine: Preparation, Characterization, and In Vivo Evaluation in Mice. Pharmaceutical Research. 18(3). 336–343. 66 indexed citations
13.
Emanuel, Noam, Eli Kedar, Elijah M. Bolotin, Nechama I. Smorodinsky, & Yechezkel Barenholz. (1996). Targeted Delivery of Doxorubicin via Sterically Stabilized Immunoliposomes: Pharmacokinetics and Biodistribution in Tumor-bearing Mice. Pharmaceutical Research. 13(6). 861–868. 50 indexed citations
14.
Barenholz, Yechezkel, Elijah M. Bolotin, Rivka Cohen, & Alberto Gabizón. (1996). Sterically Stabilized Doxorubicin Loaded Liposomes (DOX-SLTM): From Basics to the Clinics. Phosphorus, sulfur, and silicon and the related elements. 109(1). 293–296. 3 indexed citations
15.
Emanuel, Noam, Eli Kedar, Elijah M. Bolotin, Nechama I. Smorodinsky, & Yechezkel Barenholz. (1996). Preparation and Characterization of Doxorubicin-Loaded Sterically Stabilized Immunoliposomes. Pharmaceutical Research. 13(3). 352–359. 32 indexed citations
16.
Barenholz, Yechezkel, Elijah M. Bolotin, Rivka Cohen, & Alberto Gabizón. (1996). Sterically Stabilized Doxorubicin Loaded Liposomes (Dox-Sl™): From Basics to the Clinics. Phosphorus, sulfur, and silicon and the related elements. 109(1-4). 293–296. 6 indexed citations
17.
Bolotin, Elijah M., Rivka Cohen, Liliana K. Bar, et al.. (1994). Ammonium Sulfate Gradients for Efficient and Stable Remote Loading of Amphipathic Weak Bases into Liposomes and Ligandoliposomes.. Journal of Liposome Research. 4(1). 455–479. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Homer H. Chiang Breakdown of academic impact, for papers by Jordan A. Stinson Breakdown of academic impact, for papers by Sarbani Hazra Breakdown of academic impact, for papers by Lane V. Christensen Breakdown of academic impact, for papers by George R. Dakwar Breakdown of academic impact, for papers by Kelli M. Luginbuhl Breakdown of academic impact, for papers by Kevin Pham Breakdown of academic impact, for papers by Jacqueline H. Cole Breakdown of academic impact, for papers by James Floyd Breakdown of academic impact, for papers by Jeff Henise
Rankless by CCL
2026